AstraZeneca

AstraZeneca Unveils $50 Billion U.S. Investment Plan, Anchored by Massive Virginia Manufacturing Site

WILMINGTON, DE — AstraZeneca has announced a sweeping $50 billion investment across the United States through 2030, marking the company’s largest commitment to U.S. pharmaceutical operations to date. The move signals …

AstraZeneca Unveils $50 Billion U.S. Investment Plan, Anchored by Massive Virginia Manufacturing Site Read More
AstraZeneca

AstraZeneca’s TAGRISSO Combo Shows Strong Survival Benefit in EGFR-Mutated Lung Cancer

WILMINGTON, DE — AstraZeneca announced that its lung cancer therapy TAGRISSO® (osimertinib), when used in combination with chemotherapy, delivered a statistically significant and clinically meaningful improvement in overall survival for patients …

AstraZeneca’s TAGRISSO Combo Shows Strong Survival Benefit in EGFR-Mutated Lung Cancer Read More


Quavo Fraud & Disputes

Quavo Secures $300 Million Investment From Spectrum Equity to Scale AI-Driven Dispute Management Solutions

WILMINGTON, DE — Quavo, Inc. announced a $300 million investment from growth equity firm Spectrum Equity. The funding aims to accelerate product innovation, expand market reach, and deepen the company’s …

Quavo Secures $300 Million Investment From Spectrum Equity to Scale AI-Driven Dispute Management Solutions Read More